Substantial basic science and clinical evidence suggests that excess tumor necrosis factor-alpha (TNF-alpha) is centrally involved in the pathogenesis of Alzheimer's disease. In addition to its ...
The needle stays hidden during injection and a sensor can detect placement on skin. It also includes 3 difference injection speeds, a progress bar and a speaker. Amgen announced the availability of ...
In a small phase 2 study of patients with early Alzheimer's disease (AD), weekly subcutaneous administration of the tumor necrosis factor (TNF) inhibitor etanercept (Enbrel, Amgen) was well tolerated, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results